U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/About the NHLBI/Divisions, Offices and Centers/< Back ToDivision of Intramural Research/Cardiovascular Branch

Cardiovascular Branch
                    
                                                                                            Michael N. Sack, M.D., Ph.D.
				Branch Chief
				
            ms761k@nih.gov
                        The Cardiovascular Branch conducts research on diseases that affect the heart and blood vessels. Specific projects aim to answer clinically relevant questions using methods ranging from molecular level studies to clinical projects in diagnostics, therapeutics, and interventions. The Branch places a strong emphasis on creating an environment where scientists and physician scientists can work together on disease-specific issues using the most appropriate approaches available in the spectrum between the bench and the bedside. This basic research helps fuel scientific discovery that may one day help advance research related to heart, lung, blood, and sleep conditions or other fields.
            

                        Our Labs
                    
Cardiac Physiology
    In the heart, interruption of the blood supply can result in cardiac cell death and irreversible muscle damage. The Laboratory of Cardiac Physiology, led by Dr. Elizabeth Murphy, studies the molecular mechanisms involved in cardiac cell death, as well as the mechanisms that protect the heart against damage. The knowledge gained from these studies may help identify novel therapies to reduce cardiac injury during ischemia and reperfusion. Dr. Murphy’s laboratory is currently examining whether selective estrogen receptor modulators (SERMs), can mediate cardioprotection in a similar fashion to endogenous estrogen, opening up a possible therapeutic avenue to reduce heart attack damage in women.
        
            Contact:
    Elizabeth Murphy
                            Ph.D.
                            Senior Investigator
                            murphy1@mail.nih.gov
                                                                                                
        Cardiovascular Biology
    Ischemic heart disease is a leading cause of death in the U.S.  Cardiomyocytes (CMs) derived from induced pluripotent stem cells (iPSCs) have been studied as a therapy to improve cardiac function following acute or chronic ischemia. The Laboratory of Cardiovascular Biology, led by Dr. Leslie Kennedy, investigates pathways and mechanisms that can be exploited to ultimately benefit patients prone to cardiovascular pathologies. More specifically, the lab focuses on identifying novel regulators of CM maturation, establishing mechanisms by which these proteins function in Cardiomyocytes (CMs) maturation, and assessing improvements in maturation that result from perturbing expression or function of these proteins.
        
            Contact:
    Leslie Kennedy
                            Ph.D.
                            NIH Distinguished Independent Scholar
                            leslie.kennedy@nih.gov
                            301-402-1060
                                                                                                
        Cardiovascular and Cancer Genetics
    Earlier work in Dr. Hwang’s lab revealed that p53, one of the most commonly mutated tumor suppressor genes that controls multiple pathways involved in cell growth, also regulates the mitochondria as part of its adaptive activities against oxidative and other cellular stresses. The research group has performed basic and translational studies focusing on this link between cancer and mitochondrial metabolism and provided mechanistic insights for developing new cancer prevention strategies. Their work has also shown that p53 can protect the mitochondrial genome and prevent chemotherapy-induced heart failure, an observation that they are further dissecting molecularly and translating to the clinics. While continuing to examine the role of p53 in cardiac muscle homeostasis, they have recently identified specific mitochondrial genes that regulate the skeletal muscle for exercise adaptation and in chronic fatigue syndrome. The goal of these studies is to translate them for developing new strategies for improving and maintaining cardiovascular health.
        
            Contact:
    Paul M. Hwang
                            M.D., Ph.D.
                            Senior Investigator
                            hwangp@mail.nih.gov
                                                                                                
        Cardiovascular CT
    Computed tomography (CT) is a non-invasive advanced imaging test that uses x-rays to make three-dimensional pictures of the body. The Cardiovascular CT Program is focused on the development of and implementation of new imaging techniques to better diagnose heart disease and plan treatment options. This program, led by Dr. Marcus Chen, utilizes state-of-the art scanner hardware, advanced image reconstruction methods, and computational resources with a goal to reduce the overall radiation exposure needed to image a patient and detect cardiovascular disease. These new imaging techniques are not confined to the heart and vascular system, but also are being applied to other parts of the body such as the lung.
        
            Contact:
    Marcus Chen
                            M.D.
                            Assistant Clinical Investigator
                            marcus.chen@nih.gov
                                                                                                
        Cardiovascular Intervention
    The Cardiovascular Intervention program creates new catheter based treatments and devices for structural heart disease and introduces them into medical practice, under both X-ray and real-time MRI guidance. His multidisciplinary team includes cardiologists, imaging physicists, biomedical engineers, and other researchers. The program has invented procedures and devices since used on thousands of patients, including transcaval access to the aorta, BASILICA aortic leaflet modification to prevent coronary obstruction from transcatheter aortic valve replacement (TAVR), LAMPOON and ELASTIC mitral leaflet modification to enable transcatheter mitral valve implantation, mitral cerclage ventriculoplasty, MRI heart catheterization, and many others. These procedures and protocols are possible through a network of collaborating structural heart interventional cardiologists across the United States.
        
            Contact:
    Robert J. Lederman
                            M.D.
                            Senior Investigator
                            lederman@nih.gov
                                                                                                
        Clinical Physiology
    The Clinical Physiology Laboratory, led by Dr. Marcus Carlsson, focuses on developing new understanding of the mechanisms of heart failure, by means of linking technical developments of new Magnetic Resonance Imaging techniques to pre-clinical and clinical models of heart failure. Dr. Carlsson has worked with both experimental and clinical research with the aim to quantify pumping physiology, myocardial perfusion, intraventricular blood flow, tissue viability, and valvular function. Of particular importance to him is developing and validating new methodologies in multi-disciplinary collaboration with engineers.
        
            Contact:
    Marcus Carlsson
                            M.D., Ph.D.
                            Tenure Track Investigator
                            marcus.carlsson@nih.gov
                            301-402-6769
                                                                                                
        Echocardiography
    The Echocardiography Laboratory, led by Dr. Vandana Sachdev, performs comprehensive cardiac imaging for NHLBI and all institutes at the NIH Clinical Center. Researchers collaborate in prospective and retrospective cardiovascular phenotyping studies and implement new technologies for detailed assessment of ventricular systolic and diastolic function, valvular abnormalities, and structural heart disease.
        
            Contact:
    Dr. Vandana Sachdev
                            M.D.
                            Director
                            vs74y@nih.gov
                                                                                                
        Inflammation and Cardiometabolic Diseases
    The Laboratory of Inflammation and Cardiometabolic Diseases, led by Dr. Nehal Mehta, focuses on the role of innate immunity and inflammation in the development of cardiovascular and metabolic diseases. Using a trans-disciplinary approach that involves genetic epidemiology, translational medicine, and novel cardiovascular imaging approaches, Dr. Mehta and his team study how inflammation affects insulin resistance, the development of metabolic syndrome, and lipoprotein dysfunction, all of which are risk factors for atherosclerosis and cardiovascular disease.
        
            Contact:
    Nehal Mehta
                            M.D., M.S.C.E., F.A.H.A.
                            Lasker Clinical Research Scholar
                            mehtann@mail.nih.gov
                                                                                                
        Minority Health and Health Disparities
    The Minority Health and Health Disparities Laboratory focuses on health and health care disparities among racial and ethnic minority populations. The three main areas of lab research are: (1) Tobacco use behavior and its relation to other substance use, unhealthy behaviors, migration-related social determinants, chronic stress, and mental health among Latinos of different national heritages; (2) Differential risk of lung cancer in racial and ethnic minority populations, as shown by metabolic biomarkers of nicotine and tobacco-specific carcinogens; and (3) Relationships of migration- and environment-related social determinants of health with chronic diseases, such as diabetes. The Minority Health and Health Disparities Laboratory is led by Dr. Eliseo Pérez-Stable, who is also the director of the National Institute on Minority Health and Health Disparities.
        
            Contact:
    Eliseo Pérez-Stable
                            M.D.
                            Senior Investigator, NIMHD Director
                            eliseo.perez-stable@nih.gov
                                                                                                
        Mitochondrial Biology and Metabolism
    The Laboratory of Mitochondrial Biology and Metabolism, led by Dr. Michael N. Sack, focuses on modifications of proteins that play pivotal roles in metabolism and mitochondrial function to understand how these modifications affect disease risk. The major regulatory proteins being explored in the Sack laboratory include SIRT3 and GCN5L1. The effects of these nutrient- and stress-regulatory proteins on mitochondrial biology and metabolism are explored in the context of disease pathophysiology with studies in both experimental systems with translation to the human subjects. The objective of these studies is to understand how nutrient- and other stress- signaling events cause or exacerbate disease and whether therapeutic interventions can be tested that reverse these pathologies. Current diseases being explored include cardiovascular disease, insulin resistance and immune activation.
        
            Contact:
    Michael N. Sack
                            M.D., Ph.D.
                            Senior Investigator
                            sackm@nih.gov
                                                                                                
        MRI Technology
    Magnetic resonance imaging (MRI) is an established medical imaging modality, providing unparalleled soft tissue contrast combined with good spatial resolution. MRI also has the potential to provide more than just anatomical imaging, e.g. image guidance for interventional procedures, multidimensional information and tissue characterization. The MRI Technology program, led by Adrienne Campbell-Washburn, is focused on the development of advanced cardiovascular MRI techniques, leveraging modern acquisition and reconstruction techniques, as well as state-of-the-art computational resources (GPUs and cloud computing) in the clinical environment. Specifically, the aim is to improve imaging speed, imaging for MRI-guided interventions, motion robustness, quantification, and clinical workflow.
        
            Contact:
    Adrienne Campbell-Washburn
                            Ph.D.
                            Staff Scientist
                            adrienne.campbell@nih.gov
                                                                                                
        Obesity and Aging Research
    The primary research interest of the Laboratory of Obesity and Aging Research, led by Dr. Jay H. Chung, is understanding how aging and obesity affect energy metabolism and mitochondrial function and vice versa. The laboratory is elucidating the mechanisms by which aging and obesity causes mitochondrial loss and how mitochondrial dysfunction contributes to aging phenotype, including inflammation. Dr. Chung leads a translational research team seeking to discover novel therapies for diseases such as type 2 diabetes, cardiovascular diseases, neurodegeneration and autoimmune diseases by studying how mitochondrial stress affects cellular function.
        
            Contact:
    Jay H. Chung
                            Ph.D., M.D.
                            Senior Investigator
                            chungj@nhlbi.nih.gov
                                                                                                
        Obesity and Metabolic Diseases
    The broad interest of the Laboratory of Obesity and Metabolic Diseases, led by Dr. Haiming Cao, is to understand the complex regulation of energy metabolism and uncover its significance in the pathogenesis of metabolic disease. The worldwide obesity epidemic—along with an array of obesity-related disorders, particularly diabetes, fatty liver and cardiovascular diseases—has become a major public health concern for the 21st century. The molecular and pathological basis by which obesity induces metabolic disorders, however, remains only partly understood, hampering the development of effective therapies against these debilitating diseases. To address these challenging questions, the lab has recently uncovered that hundreds of long noncoding RNAs (lncRNAs), a novel class of RNAs that are produced by 90 percent of the human genome, function as vital regulators of energy metabolism. The lab has also established a humanized mouse model in which over 90 percent of the mouse liver cells are replaced by human hepatocytes, or essentially mice carrying a human liver, and is currently using this powerful model to directly study the pathophysiological significance of lncRNAs in human diseases.
        
            Contact:
    Haiming Cao
                            Ph.D.
                            Earl Stadtman Investigator
                            caoh3@nhlbi.nih.gov
                                                                                                
        Social Determinants of Obesity and Cardiovascular Risk
    It is safe to say that during the decades in which obesity has become an epidemic in the United States, the human gene pool has not been concomitantly altered. Thus, although biology and heredity do play a role in susceptibility to obesity and obesity-related disorders, the social, behavioral, and environmental contributions cannot be overlooked if effective prevention and treatment strategies are to be designed. The Social Determinants of Obesity and Cardiovascular Risk Laboratory, led by Dr. Tiffany Powell-Wiley, focuses on the social determinants of obesity and obesity-related cardiovascular risk factors that contribute to racial and ethnic disparities in cardiovascular disease. Dr. Powell-Wiley’s hope is that through a better understanding of how socioeconomic, psychosocial, and environmental factors impact obesity as a cardiovascular risk factor, she can develop interventions to reduce obesity and improve cardiovascular health tailored to community-based environments.
        
            Contact:
    Tiffany M. Powell-Wiley
                            M.D., M.P.H.
                            Stadtman Tenure Track Investigator
                            powelltm2@mail.nih.gov Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs